US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

217.06

-14.9276-6.43%

Volume:225.33K

Turnover:49.53M

Market Cap:580.53M

PE:- -

High:228.27

Open:228.27

Low:215.49

Close:231.99

52wk High:341.93

52wk Low:102.35

Shares:2.67M

Float Shares:2.67M

Volume Ratio:0.68

T/O Rate:8.43%

Dividend:0.90

Dividend Rate:0.42%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Olympus Receives FDA Warning Letter but Sees No Financial Impact

Subsidies Paid Directly to Individuals! Eligible Residents in Hohhot Urged to Apply Now

HLB Unit Elevar, Hengrui Pharma Resubmit FDA Application for Liver Cancer Treatment

MT Newswires Live

Market Chatter: Dexus Reviews Options for Healthcare Property Fund as 90% of Investors Seek Redemptions

MT Newswires Live

Nyrada Receives Supportive FDA Feedback on Heart Protection Drug Candidate

MT Newswires Live

NeuroScientific Wins FDA Backing for StemSmart Crohn’s Trial

Cleo Diagnostics Starts Key Validation Phase for Ovarian Cancer Test Ahead of FDA Bid

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Bristol-Myers Squibb (BMY) and Palvella Therapeutics (PVLA)

Health Care up Amid Deal Activity - Health Care Roundup

Industrials Flat as Traders Hedge on Growth Views - Health Care Roundup

Entero Healthcare Issues 43,155 ESOP Shares, Boosts Employee Ownership

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY) and AxoGen (AXGN)

Exchange-Traded Funds Fall as US Equities Turn Mixed After Midday

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Embecta Corporation (EMBC) and Airsculpt Technologies (AIRS)

Analysts’ Top Healthcare Picks: Cytek Biosciences (CTKB), Zimmer Biomet Holdings (ZBH)

Analysts’ Top Healthcare Picks: Vertex Pharmaceuticals (VRTX), Mineralys Therapeutics, Inc. (MLYS)

Sector Update: Healthcare

MT Newswires Live

Analysts Conflicted on These Healthcare Names: ProKidney (PROK) and Roivant Sciences (ROIV)

Analysts Conflicted on These Healthcare Names: Roche Holding AG (OtherRHHVF), Humana (HUM) and Arrowhead Pharmaceuticals (ARWR)

Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Pharvaris (PHVS) and Tenet Healthcare (THC)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://nz.tigrwd.com/stock/LABU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":217.0624,"timestamp":1791910479941,"preClose":231.99,"halted":0,"volume":225328,"delay":0,"changeRate":-0.06434587697745597,"floatShares":2674486,"shares":2674486,"eps":0,"marketStatus":"Trading","change":-14.9276,"latestTime":"10-13 12:54:42 EDT","open":228.27,"high":228.27,"low":215.491,"amount":49529631.59328,"amplitude":0.055084,"askPrice":217.78,"askSize":40,"bidPrice":217.32,"bidSize":1,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791921600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":231.99,"sharesOutstanding":3074486,"nav":242.822,"aum":649423578.22,"dividendRate":0.004168,"bidAskSpread":0.002692,"preHourTrading":{"tag":"盘前","latestPrice":228,"preClose":231.99,"latestTime":"09:29 EDT","volume":2274,"amount":529315.02324,"timestamp":1791898190029,"change":-3.99,"changeRate":-0.017199,"amplitude":0.03664},"postHourTrading":{"tag":"盘后","latestPrice":231.21,"preClose":231.99,"latestTime":"19:59 EDT","volume":3834,"amount":888365.3656,"timestamp":1791849594803,"change":-0.78,"changeRate":-0.003362,"amplitude":0.007343},"volumeRatio":0.682308,"impliedVol":0.9754,"impliedVolPercentile":0.7171},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2674486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.682308,"shares":2674486,"dividePrice":0.9048,"high":228.27,"amplitude":0.055084,"preClose":231.99,"low":215.491,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":217.0624,"committee":-0.95122,"eps":0,"divideRate":0.004168,"volume":225328,"delay":0,"ttmEps":0,"open":228.27,"prevYearClose":159.39,"prevWeekClose":243.09,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":230.95,"twentyDayClose":250.4,"sixtyDayClose":249.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2675309323","title":"Olympus Receives FDA Warning Letter but Sees No Financial Impact","url":"https://stock-news.laohu8.com/highlight/detail?id=2675309323","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675309323?lang=en_us&edition=fundamental","pubTime":"2026-10-13 17:24","pubTimestamp":1791883489,"startTime":"0","endTime":"0","summary":"Olympus ( ($JP:7733) ) just unveiled an update. Olympus has disclosed that it received a Warning Letter from the U.S. Food and Drug Administration ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/olympus-receives-fda-warning-letter-but-sees-no-financial-impact?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/olympus-receives-fda-warning-letter-but-sees-no-financial-impact?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140969499","title":"Subsidies Paid Directly to Individuals! Eligible Residents in Hohhot Urged to Apply Now","url":"https://stock-news.laohu8.com/highlight/detail?id=1140969499","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140969499?lang=en_us&edition=fundamental","pubTime":"2026-10-13 16:11","pubTimestamp":1791879090,"startTime":"0","endTime":"0","summary":"Recently, there has been a high volume of policy inquiries. The Hohhot Municipal Human Resources and Social Security Bureau has systematically compiled and summarized frequently asked questions from...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","LABU","BK4588","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675386211","title":"HLB Unit Elevar, Hengrui Pharma Resubmit FDA Application for Liver Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2675386211","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675386211?lang=en_us&edition=fundamental","pubTime":"2026-10-13 08:42","pubTimestamp":1791852129,"startTime":"0","endTime":"0","summary":"HLB's  US subsidiary Elevar Therapeutics and partner Jiangsu Hengrui Pharmaceuticals  have resubmitted a New Drug Application and Biologics License Application to the US Food and Drug Administration for rivoceranib combined with camrelizumab as a liver cancer treatment.The resubmission follows a Complete Response Letter issued by the FDA in July, which centered on manufacturing facility inspection observations.The filing is supported by data from the global Phase 3 CARES-310 trial, showing a median overall survival of 23.8 months compared with 15.2 months for sorafenib, representing a 36% reduction in the risk of death, according to a joint statement on Monday.The combination therapy has already been recognized in the 2025 Barcelona Liver Cancer Clinic treatment strategy and ESMO guidelines as a first-line treatment option.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["600276","LU2097828805.USD","LU1781817850.SGD","BK0188","BK1191","BK0196","LU1064131003.USD","LU0359201885.HKD","LU2097828631.EUR","LU0359202008.SGD","LU1655091616.SGD","LU1255011170.USD","BK0012","LU2097828557.USD","LU2097828714.EUR","BK0028","LU1064130708.USD","LU1328615791.USD","LU1997244956.HKD","BK4585","BK0239","LU1997245177.USD","LU2328871848.SGD","LU2097828474.EUR","LU0405327494.USD","LU1969619763.USD","LU1146622755.USD","LU2495084118.USD","LU0405327148.USD","LU2580892862.HKD","LU1023057109.AUD","LU1997245094.SGD","LU1580142542.USD","BK0060","LU2148510915.USD","BK4588","LABU","01276","LU0359201612.USD","LU1820825898.SGD","LU2580892789.USD","LU2289578879.USD","LU2543165471.USD","BK0183","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675938666","title":"Market Chatter: Dexus Reviews Options for Healthcare Property Fund as 90% of Investors Seek Redemptions","url":"https://stock-news.laohu8.com/highlight/detail?id=2675938666","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675938666?lang=en_us&edition=fundamental","pubTime":"2026-10-13 08:28","pubTimestamp":1791851284,"startTime":"0","endTime":"0","summary":"Dexus  is reviewing options for its Dexus Healthcare Property Fund after it did not scale to expectations following its establishment in 2017, the Australian Financial Review reported late Monday, citing anonymous sources briefed on the matter.The company has engaged corporate advisory firm Denison Partners to help review options that include asset disposals, different capital and ownership structures, and a complete wind-down, according to the report.The review comes after Dexus reportedly received redemption requests from 90% of the fund's investors.The company declined to comment when reached by MT Newswires.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7510","JJJ.SI","HCSG","LU0128526141.USD","DXS.AU","BK7122","BK4585","SRU.SI","BK4581","SRT.SI","BK4211","CLR.SI","GLS.SI","BK4588","XLV","BK4137","XBI","LABU","LU0029874061.USD","BK7154","ISBC","CFA.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675368385","title":"Nyrada Receives Supportive FDA Feedback on Heart Protection Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2675368385","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675368385?lang=en_us&edition=fundamental","pubTime":"2026-10-13 07:38","pubTimestamp":1791848304,"startTime":"0","endTime":"0","summary":"Nyrada  received supportive written feedback from the US Food and Drug Administration  on its pre-investigational new drug  meeting request for Xolatryp, with no major issues identified, according to a Tuesday filing with the Australian bourse.Xolatryp is being developed to protect the heart tissue from damage.The FDA deemed the nonclinical safety data, proposed clinical design, cardiac safety monitoring, and chemistry, manufacturing and controls package generally adequate to support the planned phase 2a PROTECT-MI trial in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention, while requesting additional information to complete the IND submission, the filing said.The FDA said that a future fast-track designation request could be appropriate, depending on the design of a subsequent phase three trial, per the filing.The company remains on schedule to file its US IND in the first half of 2027 while accelerating recruitment for the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","NYR.AU","BK4588","BK7096","IND.AU","LABU","BK7095","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675131383","title":"NeuroScientific Wins FDA Backing for StemSmart Crohn’s Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2675131383","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675131383?lang=en_us&edition=fundamental","pubTime":"2026-10-13 06:54","pubTimestamp":1791845648,"startTime":"0","endTime":"0","summary":"Neuroscientific Biopharmaceuticals Ltd. ( ($AU:NSB) ) has shared an announcement. NeuroScientific Biopharmaceuticals has secured positive regulator...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neuroscientific-wins-fda-backing-for-stemsmart-crohns-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neuroscientific-wins-fda-backing-for-stemsmart-crohns-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675880423","title":"Cleo Diagnostics Starts Key Validation Phase for Ovarian Cancer Test Ahead of FDA Bid","url":"https://stock-news.laohu8.com/highlight/detail?id=2675880423","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675880423?lang=en_us&edition=fundamental","pubTime":"2026-10-13 06:07","pubTimestamp":1791842846,"startTime":"0","endTime":"0","summary":"The latest update is out from CLEO Diagnostics Ltd ( ($AU:COV) ). Cleo Diagnostics has begun Analytical Validation of its pre-surgical ovarian canc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cleo-diagnostics-starts-key-validation-phase-for-ovarian-cancer-test-ahead-of-fda-bid?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cleo-diagnostics-starts-key-validation-phase-for-ovarian-cancer-test-ahead-of-fda-bid?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675838842","title":"Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Bristol-Myers Squibb (BMY) and Palvella Therapeutics (PVLA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2675838842","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675838842?lang=en_us&edition=fundamental","pubTime":"2026-10-13 06:00","pubTimestamp":1791842428,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roivant Sciences (ROIV), Bristol-Myers Squibb (BMY...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-roivant-sciences-roiv-bristol-myers-squibb-bmy-and-palvella-therapeutics-pvla-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-roivant-sciences-roiv-bristol-myers-squibb-bmy-and-palvella-therapeutics-pvla-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LU1093756168.USD","LU0985481810.HKD","LU1236620750.USD","BK4137","LU1670711040.USD","IE00BSNM7G36.USD","LU0456855351.SGD","BK4559","LU0432979614.USD","LU2125154778.USD","LU2133065610.SGD","LU1236620834.HKD","FTXH","LU1983299246.USD","PVLA","HCSG","LU2242646821.SGD","LU1261432733.SGD","PTH","LU1430594728.SGD","LU0306807586.USD","BK4532","BMY","BK4534","LABU","LU1718418525.SGD","LU0321505868.SGD","LU1883839398.USD","LU1323610961.USD","LU0306806265.USD","LU1074936037.SGD","LU1585245621.USD","LU1670710661.SGD","LU1868837300.USD","IHE","BK4585","LU0237698245.USD","LU0225284248.USD","BK4588","LU1868836591.USD","LU0096364046.USD","ROIV","LU1291159041.SGD","XLV","LU2125154935.USD","IE00BFXG1179.USD","BK4007","LU1571399168.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675800233","title":"Health Care up Amid Deal Activity - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2675800233","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675800233?lang=en_us&edition=fundamental","pubTime":"2026-10-13 04:50","pubTimestamp":1791838200,"startTime":"0","endTime":"0","summary":"Health-care companies rose amid deal activity.Hospital supplier Steris agreed to buy specialty-surgical-products company Xodus Medical for $2.1 billion.Bristol Myers Squibb shares fell despite a promising update from a major cancer-drug trial.Investors responded negatively to mixed data from a late-stage trial of a lung-condition treatment candidate from Bristol Myers.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XBI","BK4581","XLV","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675180025","title":"Industrials Flat as Traders Hedge on Growth Views - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2675180025","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675180025?lang=en_us&edition=fundamental","pubTime":"2026-10-13 04:50","pubTimestamp":1791838200,"startTime":"0","endTime":"0","summary":"Shares of industrial and transportation companies were more or less flat as traders hedged their bets on the outlook for global economic growth.The European Union plans to cap hybrid-vehicle imports f","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4585","XLV","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675580796","title":"Entero Healthcare Issues 43,155 ESOP Shares, Boosts Employee Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2675580796","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675580796?lang=en_us&edition=fundamental","pubTime":"2026-10-13 02:54","pubTimestamp":1791831287,"startTime":"0","endTime":"0","summary":"Entero Healthcare Solutions Limited ( ($IN:ENTERO) ) just unveiled an announcement. Entero Healthcare Solutions Limited has approved the allotment ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/entero-healthcare-issues-43155-esop-shares-boosts-employee-ownership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/entero-healthcare-issues-43155-esop-shares-boosts-employee-ownership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XLV","BK4137","BK4585","LU0029874061.USD","HCSG","XBI","LABU","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675801051","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY) and AxoGen (AXGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2675801051","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675801051?lang=en_us&edition=fundamental","pubTime":"2026-10-13 01:20","pubTimestamp":1791825605,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bristol-Myers Squibb (BMY) and AxoGen (AXGN). Bris...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-bristol-myers-squibb-bmy-and-axogen-axgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-bristol-myers-squibb-bmy-and-axogen-axgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1430594728.SGD","AXGN","LU1868836914.USD","BK4588","IE00BFTCPJ56.SGD","LU0061475181.USD","XLV","LU2125154935.USD","LABU","LU1291159041.SGD","LU0128526141.USD","LU1074936037.SGD","BK4534","LU0096364046.USD","LU0432979614.USD","LU0456855351.SGD","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU0114720955.EUR","BMY","HCSG","LU0237698245.USD","LU0321505439.SGD","IE00BJT1NW94.SGD","BK4137","LU1670710661.SGD","LU0985481810.HKD","LU0306807586.USD","BK4559","LU0321505868.SGD","IE0009355771.USD","BK4007","LU2360032135.SGD","BK4532","IHE","LU1236620750.USD","XBI","LU1868837300.USD","LU0882574055.USD","LU1261432733.SGD","LU1236620834.HKD","LU1585245621.USD","BK4082","LU0868494617.USD","LU1032466523.USD","LU1883839398.USD","IE0002141913.USD","FTXH","LU1868836591.USD","LU0225771236.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675801447","title":"Exchange-Traded Funds Fall as US Equities Turn Mixed After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2675801447","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675801447?lang=en_us&edition=fundamental","pubTime":"2026-10-13 01:11","pubTimestamp":1791825108,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV fell. Actively traded Invesco QQQ Trust (QQQ) lost 0.7%.US equity indexes traded mixed as technology and consumer discretionary de","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BFJL","UGL","BTCZ","KGLD","GLL","BCCC","SCO","BTCO","BITB","SOXS","TQQQ","BK4581","QQQM","CBOO","IYW","BTC.USD.CC","XBI","MAXI","XRT","BETE","QQQ","QQQX","SIVR","SQQQ","VHT","NDX","USO","BK4570","EZBC","IGM","GBTC","ETHT","BTCC","MNRS","QMAR","TQQY","ETQ","BITO","CBOA","BK4547","ARKB","TECL","BK4561","GLDY","BAGY","CBTO","IAUI","BK4550","IBB","RTH","SETH","IAUM","BITU","SBIT","ETH","BGLD","IGLD","QID","BETH","AGQ","IYE","RETL","VIS","UNG","XLPD","TETH","GLDM","XLE","BITX","EETH","FAS","BPI","ETHD","CBOJ","FBTC","BK4585","SOXL","SOXX","QBF","IAU","AAAU","NAPR","PSQ","IYJ","ETCO","XLY","DZZ","FAZ","OUNZ","QLD","CBTY","XLK","BRRR","YGLD","BK4588","BK4504","GLD","XLF","ESK","GPIQ","CBXA","VDC","XBTY","CBXY","XAUUSD.FOREX","XSD","BTF","XLPU","BITI","CBXJ","NJAN","DEFI","ZSL","SHNY","IBIT","BTRN","DGP","USG","XLI","BITY","FGDL","CBXO","NOCT","LABU","DULL","BTC","ETH.USD.CC","BTCI","BTCL","CBTA","DFII","BK4534","DGZ","UCO","SGOL","BAR","IYH","CBTJ","BK4593","SLV","BFAP","YBTC","XLV","CBOY","XLP","QDEC","HODL","NJUL","BTCW","XAGUSD.FOREX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674803239","title":"Analysts Offer Insights on Healthcare Companies: Embecta Corporation (EMBC) and Airsculpt Technologies (AIRS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674803239","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674803239?lang=en_us&edition=fundamental","pubTime":"2026-10-12 22:00","pubTimestamp":1791813639,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on Embecta Corporation (EMBC) and Airsculpt Technologies (AIRS) with neutral ratings, indicating that th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-embecta-corporation-embc-and-airsculpt-technologies-airs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-embecta-corporation-embc-and-airsculpt-technologies-airs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0029874061.USD","BK4198","BK4581","BK4137","BK4588","LU0128526141.USD","AIRS","LABU","BK4196","EMBC","HCSG","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674425803","title":"Analysts’ Top Healthcare Picks: Cytek Biosciences (CTKB), Zimmer Biomet Holdings (ZBH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674425803","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674425803?lang=en_us&edition=fundamental","pubTime":"2026-10-12 21:50","pubTimestamp":1791813014,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on Cytek Biosciences (CTKB), Zimmer Biomet Holdings (ZBH) and Senseonics Holdings (SENS) with neutral ra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-cytek-biosciences-ctkb-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-cytek-biosciences-ctkb-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0128525929.USD","BK4566","LU0310799852.SGD","LU0980610538.SGD","BK4581","LU1267930813.SGD","LU0029864427.USD","ZBH","BK4121","LABU","LU1201861249.SGD","LU0708994859.HKD","LU1267930573.SGD","LU0477156953.USD","LU0310800379.SGD","LU0130517989.USD","LU0211327993.USD","LU0211328371.USD","LU0006061336.USD","IE00B19Z3B42.SGD","BK4539","IE00B19Z3581.USD","LU0130102774.USD","BK4082","LU1267930490.SGD","LU0029874061.USD","IE0002270589.USD","HCSG","XBI","IE00B7SZLL34.SGD","BK4588","BK4137","LU0128526141.USD","LU0792757196.USD","LU0648001328.SGD","SENS","CTKB","LU0889566641.SGD","BK4504","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674808117","title":"Analysts’ Top Healthcare Picks: Vertex Pharmaceuticals (VRTX), Mineralys Therapeutics, Inc. (MLYS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674808117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674808117?lang=en_us&edition=fundamental","pubTime":"2026-10-12 21:20","pubTimestamp":1791811228,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX) and Mineralys Therapeu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-vertex-pharmaceuticals-vrtx-mineralys-therapeutics-inc-mlys-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-vertex-pharmaceuticals-vrtx-mineralys-therapeutics-inc-mlys-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B4R5TH58.HKD","BBH","LU1674673691.USD","PBE","LABU","LU0058720904.USD","LU1430594728.SGD","IBB","LU1559883803.SGD","XBI","LU1093756168.USD","BK4137","IBBQ","MLYS","IE00BZ9MQY76.HKD","SG9999001176.USD","IE00B19Z9Z06.USD","GNMX","SGXZ57979304.SGD","IE00B894F039.SGD","LU0566484027.USD","IE00BFTCPJ56.SGD","LU2089984988.USD","HCSG","LU1674673428.USD","BIB","IDNA","IE0002141913.USD","LU0432979614.USD","LU2417539215.USD","BK4533","BK4567","LU1035775433.USD","LU2362541273.HKD","VERX","LU0889565916.HKD","XLV","TBXU","BK4532","IE0002270589.USD","LU0109394709.USD","BK4585","LU1069344957.HKD","LU2237438978.USD","VRTX","LU1815336091.USD","LU2468319806.SGD","LU1585245621.USD","BK4139","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674808344","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2674808344","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674808344?lang=en_us&edition=fundamental","pubTime":"2026-10-12 21:05","pubTimestamp":1791810335,"startTime":"0","endTime":"0","summary":"Healthcare stocks were higher premarket Monday, with the State Street Health Care Select Sector SPDR ETF  gaining 0.4% and the iShares Biotechnology ETF  advancing 0.1%.Humana  stock was up more than 1% premarket after DataMeds AI  said its Helomics subsidiary received a Medicaid coverage determination from Humana for its ChemoFx test in gynecologic cancers.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCSG","LU0417517546.SGD","LU1093756168.USD","XBI","HUM.AU","LU0170899867.USD","LU1093756325.SGD","LABU","IE00BGHQF748.EUR","FXH","FDN","LU0256863811.USD","LU1883839398.USD","BK4550","XLV","IBB","SG9999014013.SGD","BK4566","LU1983260115.SGD","BK4175","BK7500","MEDS","IHF","SG9999014021.USD","HUM","BK4581","LU0070302665.USD","LU0211331839.USD","BK4154","LU1894683264.USD","LU0238689110.USD","SG9999014005.SGD","BK4137","BK4167","BK4585","BK4135","STT","IE00B3QW5Z07.USD","LU0208291251.USD","LU0320765489.SGD","LU0348723411.USD","LU0390134368.USD","BK4533","BK7093","BK4588","LU0128526141.USD","LU0266013472.USD","LU1894683348.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674088878","title":"Analysts Conflicted on These Healthcare Names: ProKidney (PROK) and Roivant Sciences (ROIV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674088878","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674088878?lang=en_us&edition=fundamental","pubTime":"2026-10-12 20:50","pubTimestamp":1791809416,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on ProKidney (PROK) and Roivant Sciences (ROIV). ProKidney (PROK) Ba...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-prokidney-prok-and-roivant-sciences-roiv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-prokidney-prok-and-roivant-sciences-roiv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PROK","LU0128526141.USD","ROIV","XBI","LU0029874061.USD","BK4137","BK4585","BK4588","HCSG","PTH","BK4139","LABU","BK4007","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674870696","title":"Analysts Conflicted on These Healthcare Names: Roche Holding AG (OtherRHHVF), Humana (HUM) and Arrowhead Pharmaceuticals (ARWR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674870696","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674870696?lang=en_us&edition=fundamental","pubTime":"2026-10-12 20:40","pubTimestamp":1791808811,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF), Humana (HUM) and Arrowhe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-roche-holding-ag-otherrhhvf-humana-hum-and-arrowhead-pharmaceuticals-arwr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-roche-holding-ag-otherrhhvf-humana-hum-and-arrowhead-pharmaceuticals-arwr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0070302665.USD","FXH","XBI","BK4533","IHF","SG9999014005.SGD","LU0211331839.USD","BK4566","SG9999014013.SGD","LU2293690249.USD","LABU","ARWR","LU0256863811.USD","LU0266013472.USD","BK4585","LU0128526141.USD","LU0348723411.USD","LU1983260115.SGD","LU0208291251.USD","LU0417517546.SGD","LU1046234339.USD","RHHVF","BK4581","LU2539964713.USD","BK4139","LU0029874061.USD","LU0170899867.USD","BK4007","LU1093756168.USD","XLV","SG9999014021.USD","LU0390134368.USD","HUM","HCSG","LU0238689110.USD","LU1093756325.SGD","LU2293690082.USD","BK4154","BK4137","BK4588","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674877704","title":"Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Pharvaris (PHVS) and Tenet Healthcare (THC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674877704","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674877704?lang=en_us&edition=fundamental","pubTime":"2026-10-12 20:20","pubTimestamp":1791807650,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Henry Schein (HSIC), Pharvaris (PHVS) and Tenet Healthcare (THC)....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-henry-schein-hsic-pharvaris-phvs-and-tenet-healthcare-thc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-henry-schein-hsic-pharvaris-phvs-and-tenet-healthcare-thc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1201861165.SGD","LU2324357040.USD","HSIC","LABU","THC","BK4581","LU0963586101.USD","BK4007","PHVS","LU0130103400.USD","BK4175","XBI","LU0648000940.SGD","LU0757428866.USD","XLV","LU1815336091.USD","BK4588","BK4185"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":2,"totalSize":396,"code":"91000000","status":"200"}]}}